|
| 37316834 | Microglial cell response to experimental periodontal disease. | | 2023 |
| 36410428 | Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer's disease. | Brain Research | 2023 |
| 37160207 | Fingolimod mitigates memory loss in a mouse model of Gulf War Illness amid decreasing the activation of microglia, protein kinase R, and NFκB. | | 2023 |
| 34643147 | Dementia and the Risk of Periodontitis: A Population-Based Cohort Study. | | 2022 |
| 35813949 | The Periodontal Pathogen <i>Fusobacterium nucleatum</i> Exacerbates Alzheimer's Pathogenesis <i>via</i> Specific Pathways. | Front Aging Neurosci | 2022 |
| 33122702 | Microglial response to experimental periodontitis in a murine model of Alzheimer's disease. | Scientific Reports | 2020 |
| 32155778 | A Preliminary Study of Cu Exposure Effects upon Alzheimer's Amyloid Pathology. | Biomolecules | 2020 |
| 31358793 | Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease. | Sci Rep | 2019 |
| 30498985 | Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease. | J Mol Neurosci | 2019 |
| 29277710 | Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease. | Brain Research | 2018 |
| 29526415 | Corrigendum to "Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of Gulf War illness in a mouse model of the disease" [Brain Res. 1681 (2018) 34-43]. | Brain Research | 2018 |
| 29126887 | Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease. | Experimental Neurology | 2018 |
| 29510124 | Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease. | European Journal of Pharmacology | 2018 |
| 26581500 | Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration. | Neuropharmacology | 2016 |
| 27117087 | Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease. | Sci Rep | 2016 |
| 24614496 | Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease. | Mol Psychiatry | 2015 |
| 24637017 | 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. | Neurosci Lett | 2014 |
| 25301691 | The effects of aging, housing and ibuprofen treatment on brain neurochemistry in a triple transgene Alzheimer's disease mouse model using magnetic resonance spectroscopy and imaging. | Brain Research | 2014 |
| 23365232 | The antiaging protein Klotho enhances oligodendrocyte maturation and myelination of the CNS. | Journal of Neuroscience | 2013 |
| 24120437 | Combination therapy in a transgenic model of Alzheimer's disease. | Exp Neurol | 2013 |
| 24161403 | R-flurbiprofen improves tau, but not Aÿ pathology in a triple transgenic model of Alzheimer's disease. | Brain Res | 2013 |
| 19968977 | Moderate exercise delays the motor performance decline in a transgenic model of ALS. | Brain Res | 2010 |
| 19679126 | Anti-inflammatory treatment in AD mice protects against neuronal pathology. | Exp Neurol | 2010 |
| 20399219 | Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models. | Neuropharmacology | 2010 |
| 20118741 | Longitudinal monitoring of motor neuron circuitry in FALS rats using in-vivo phMRI. | NeuroReport | 2010 |
| 19930399 | Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. | European Journal of Neuroscience | 2009 |
| 19423757 | Extralarge XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a distinct, membrane-anchored GNAS product that can mimic Gs(alpha). | Endocrinology | 2009 |
| 18374906 | Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice. | Brain Res | 2008 |
| 18032664 | Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice. | J Neurosci | 2007 |
| 17451183 | Application of MRS to mouse models of neurodegenerative illness. | NMR in Biomedicine | 2007 |
| 16135087 | Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. | J Neurochem | 2005 |
| 15147513 | 3-Nitropropionic acid-induced neurotoxicity--assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy. | Journal of Neurochemistry | 2004 |
| 15582280 | Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis. | Exp Gerontol | 2004 |
| 15158161 | Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. | Brain Res | 2004 |
| 12604778 | Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease. | Proc Natl Acad Sci U S A | 2003 |
| 12787055 | Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice. | J Neurochem | 2003 |
| 12586550 | Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. | Neurobiol Dis | 2002 |
| 11978494 | Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. | Free Radic Biol Med | 2002 |
| 12388601 | Therapeutic effects of cystamine in a murine model of Huntington's disease. | J Neurosci | 2002 |
| 12095160 | Cytochrome C and caspase-9 expression in Huntington's disease. | Neuromolecular Med | 2002 |
| 12093104 | Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid. | Exp Neurol | 2002 |
| 11880489 | Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. | J Neurosci | 2002 |
| 11299300 | Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. | J Neurochem | 2001 |
| 11711888 | Lipoic acid improves survival in transgenic mouse models of Huntington's disease. | Neuroreport | 2001 |
| 11456300 | Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease. | Ann Neurol | 2001 |
| 11752065 | Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. | J Neurochem | 2001 |
| 11447996 | Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease. | Neurobiol Dis | 2001 |
| 11665866 | Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis. | Journal of Molecular Neuroscience | 2001 |
| 11259130 | Effects of an inhibitor of poly(ADP-ribose) polymerase, desmethylselegiline, trientine, and lipoic acid in transgenic ALS mice. | Exp Neurol | 2001 |
| 11259123 | Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. | Exp Neurol | 2001 |